Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil plus choline alfoscerate in Alzheimer's disease with associated vascular damage
2008-005969-55Phase 2Active
- Sponsor
- Cardarelli Hospital
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of donepezil and choline alfoscerate in Alzheimer's disease (AD) (2 arms), sponsored by Cardarelli Hospital. Primary endpoint: Cognitive deterioration assessment. Started Nov 2008; status: active.
02
Drugs
donepezilcholine alfoscerate
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2008-005969-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005969-55.